Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.38 |
| ▸ | PPARA | Q07869 | 3/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 11/20 | 0.35 |
| ▸ | CNR1 | P21554 | 2/20 | 0.34 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.34 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | FBP1 | P09467 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL198732 | 0.90 | PPARA (0.37) | CYP3A4PPARAABCB11CYP1A2TSHR | |
| SCHEMBL200870 | 0.90 | PPARA (0.38) | CYP3A4PPARAABCB11CYP1A2TSHR | |
| SCHEMBL198390 | 0.85 | KCNH2 (0.38) | CYP3A4PPARACYP1A2NR1H4CYP2C9 | |
| SCHEMBL198482 | 0.82 | DGAT1 (0.39) | CYP3A4PPARACYP1A2NR1H4KCNH2 | |
| SCHEMBL198630 | 0.80 | CHEK2 (0.43) | CYP3A4NR1H4CYP2C9KCNH2CYP2D6 | |
| SCHEMBL198729 | 0.80 | PPARA (0.37) | CYP3A4PPARAABCB11CYP1A2TSHR | |
| SCHEMBL197542 | 0.78 | NR1H4 (0.51) | CYP3A4NR1H4CYP2C9KCNH2CYP2D6 | |
| SCHEMBL198387 | 0.74 | PDE5A (0.38) | CYP3A4PPARACYP1A2NR1H4KCNH2 | |
| SCHEMBL200871 | 0.72 | PPARA (0.42) | CYP3A4PPARAABCB11CYP1A2TSHR | |
| SCHEMBL200872 | 0.72 | PPARA (0.42) | CYP3A4PPARAABCB11CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088930-B2 | Benzimidazole derivatives | HOFFMANN-LA ROCHE INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20100063101-A1 | NEW BENZIMIDAZOLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063101-A1 | NEW BENZIMIDAZOLE DERIVATIVES | CYP3A7, ECI1, CYP2B6 | CYP3A4 4/4885PPARA 322/4885ABCB11 43/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.